Asymptomatic women with COVID-19 diagnosis only have increased risks for maternal morbidity and preeclampsia
FRIDAY, April 23, 2021 (HealthDay News) — COVID-19 in pregnancy is associated with increased severe maternal morbidity and mortality, according to a study published online April 22 in JAMA Pediatrics.
José Villar, M.D., from the University of Oxford in the United Kingdom, and colleagues examined the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared to noninfected pregnant individuals in a cohort study involving 43 institutions in 18 countries. Data were included for 706 pregnant women with a COVID-19 diagnosis and 1,424 pregnant women without a COVID-19 diagnosis, with broadly similar demographic characteristics.
The researchers found that 48.6 percent of women with a COVID-19 diagnosis and 40.2 percent without had overweight early in pregnancy. Increased risks for preeclampsia/eclampsia, severe infections, intensive care unit admission, maternal mortality, preterm birth, medically indicated preterm birth, severe neonatal morbidity index, and severe perinatal morbidity and mortality index were seen for women with a COVID-19 diagnosis (relative risks [RRs], 1.76, 3.38, 5.04, 22.3, 1.59, 1.97, 2.66, and 2.14, respectively). There was a correlation noted for fever and shortness of breath of any duration with an increased risk of severe maternal complications and neonatal complications (RRs, 2.56 and 4.97, respectively). Only risks for maternal morbidity and preeclampsia remained increased for asymptomatic women with a COVID-19 diagnosis (RRs, 1.24 and 1.63, respectively). Thirteen percent of the neonates of women who tested positive also tested positive. The risk for neonatal test positivity was increased for cesarean delivery but not breastfeeding.
“We demonstrated that women with COVID-19 diagnosis, compared with those without COVID-19 diagnosis, were at substantially increased risk of severe pregnancy complications,” the authors write.
One author disclosed financial ties to Ferring Pharmaceutical and Bayer; a second author disclosed ties to Intelligent Ultrasound.
Mom"s Poor Sleep in Late Pregnancy Linked to Offspring"s Obesity Risk in Early Childhood 
High Intake of Eggs, Peanuts in Pregnancy Does Not Lower Allergy Risk 
Altered Markers of Ovarian Development Seen With Fetal Acetaminophen Exposure .jpg)
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy 
Higher Parental Vitamin B12 Tied to Lower Prevalence of Birth Defects 
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Dose-Dependent Link Seen for Clomiphene Citrate, Adverse Perinatal Outcomes 
Effect of Preparation Techniques Before Embryo Transfer Appears to Be Limited 
